Trial Details

COMPLETED
Basic Information
Clinical ID c4236
Identifier NCT00805766
Trial Title Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: TA-650
Participant Information
Sponsor Tanabe Pharma Corporation
City Hokkaido
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2008-12
Primary Completion Date 2009-11
Completion Date 2010-07